WT1 mRNA was overexpressed in 91% of diagnosis phase AML patients’ bone marrow as compared to normal bone marrow (Supplementary Table S6 and Figure 1b), whereas EVI1 overexpression was observed in 13% (Figure 1c) of the patients. Here, WT1 is linked to acute myeloid leukemia.